XPH

SPDR S&P Pharmaceuticals ETF

Down$41.20
$-1.19
(-2.81%)
As of 12:00:00 AM EDT | 3/22/19  |  Market Closed

XPH Trading Data

Open

$42.29

Low Price

$41.16

High Price

$42.29

Previous Last Price

$42.39

Bid Size

$0 X 0

Ask Size

$0 X 0

XPH Portfolio Data

AUM

$252,229,000

Shares

5,950

PE Ratio

10.87

Price / Book Ratio

2.23

Expense Ratio

0.35

Net Asset Value

$42.39

Volume

Volume

82,600

Avg. Volume (YDT)

64,586

Dollar Volume

$3,044,227

Weekly Avg. Volume

67,060

Monthly Avg. Volume

64,795

Quarterly Avg. Volume

68,874

XPH Fund Description

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

XPH Chart

XPH Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Pharmaceuticals ETF

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

XPH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XPH Holdings

Top 10 Holdings

Elanco Animal Health Inc. (ELAN)
4.78%
Mylan N.V. (MYL)
4.76%
Zoetis Inc. Class A (ZTS)
4.67%
Allergan plc (AGN)
4.58%
Perrigo Co. Plc (PRGO)
4.52%
Merck & Co. Inc. (MRK)
4.5%
Pfizer Inc. (PFE)
4.48%
Jazz Pharmaceuticals Plc (JAZZ)
4.44%
Eli Lilly and Company (LLY)
4.39%
Johnson & Johnson (JNJ)
4.33%

Total XPH Holdings

Total Holdings: 44

Elanco Animal Health Inc. (ELAN)
4.78%
Mylan N.V. (MYL)
4.76%
Zoetis Inc. Class A (ZTS)
4.67%
Allergan plc (AGN)
4.58%
Perrigo Co. Plc (PRGO)
4.52%
Merck & Co. Inc. (MRK)
4.5%
Pfizer Inc. (PFE)
4.48%
Jazz Pharmaceuticals Plc (JAZZ)
4.44%
Eli Lilly and Company (LLY)
4.39%
Johnson & Johnson (JNJ)
4.33%
Nektar Therapeutics (NKTR)
4.13%
Bristol-Myers Squibb Company (BMY)
4.12%
Mallinckrodt Plc (MNK)
4.12%
Catalent Inc (CTLT)
3.76%
Horizon Pharma plc (HZNP)
3.42%
Medicines Company (MDCO)
2.9%
Endo International Plc (ENDP)
2.82%
Aerie Pharmaceuticals Inc. (AERI)
2.69%
Pacira Pharmaceuticals Inc. (PCRX)
2.35%
Supernus Pharmaceuticals Inc. (SUPN)
2.15%
Zogenix Inc. (ZGNX)
2.07%
Corcept Therapeutics Incorporated. (CORT)
1.88%
MyoKardia Inc. (MYOK)
1.85%
Innoviva Inc. (INVA)
1.84%
Prestige Consumer Healthcare Inc (PBH)
1.71%
TherapeuticsMD Inc. (TXMD)
1.56%
Reata Pharmaceuticals Inc. Class A (RETA)
1.47%
Amneal Pharmaceuticals Inc. Class A (AMRX)
1.27%
Omeros Corporation (OMER)
1.01%
Akorn Inc. (AKRX)
0.96%
Intersect ENT Inc (XENT)
0.91%
Wave Life Sciences Ltd. (WVE)
0.9%
Revance Therapeutics Inc. (RVNC)
0.69%
Collegium Pharmaceutical Inc. (COLL)
0.62%
CymaBay Therapeutics Inc. (CBAY)
0.57%
Intra-Cellular Therapies Inc. (ITCI)
0.52%
Theravance Biopharma Inc (TBPH)
0.51%
Phibro Animal Health Corporation Class A (PAHC)
0.47%
ANI Pharmaceuticals Inc. (ANIP)
0.43%
Tricida Inc (TCDA)
0.42%
Amphastar Pharmaceuticals Inc (AMPH)
0.38%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.02%
SPDR S & P Pharmaceuticals ETF (XPH)
0%
U.S. Dollar
0%

XPH Technicals

Alpha

-12.84

Beta

1.37

Leverage

Long

Standard Deviation

3.31

XPH Dividends

Dividend Date

2019-03-18

Latest Dividend

0.068

Annual Dividend

0.29

Annual Dividend Rate

0.29

Annual Dividend Yield

0.68

XPH Performance

YTD Return

12.51%

1 Year Return

-2.07%

3 Year Return

4.6%

5 Year Return

-9.86%

10 Year Return

204.85%

XPH Related Articles